Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
ClinicalTrials.gov study NCT01078441. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00075881. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
ClinicalTrials.gov study NCT02669615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)
ClinicalTrials.gov study NCT04682405. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
ClinicalTrials.gov study NCT01463670. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03030261. IPD Sharing: NO. Countries: 2. Publications: 0.
Study Evaluating the Safety and Efficacy of JCARH125 in Subjects With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03430011. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00985907. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT00434161. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT04458831. IPD Sharing: YES. Countries: 21. Publications: 0.
Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients
ClinicalTrials.gov study NCT00401011. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT00185614. IPD Sharing: NO. Countries: 1. Publications: 0.
Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02086552. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00687674. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02548962. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM)
ClinicalTrials.gov study NCT01651039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Serum NGAL IN Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05439538. IPD Sharing: Not stated. Countries: 0. Publications: 8.
Antineoplaston Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00003511. IPD Sharing: NO. Countries: 1. Publications: 0.
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
ClinicalTrials.gov study NCT04314752. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
ClinicalTrials.gov study NCT06504524. IPD Sharing: NO. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.